Adenocarcinoma pancreas – Basic Information

Go back

Pancreatic adenocarcinoma is a challenging disease that affects the pancreas, a vital organ tucked behind the stomach that helps digest food and regulate blood sugar levels. Understanding this condition can empower patients and families to make informed decisions during their cancer journey.

Understanding Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma is the most common type of pancreatic cancer, making up approximately 90 to 95 percent of all pancreatic cancer cases.[4][5] This disease develops when cells in the pancreas begin to multiply uncontrollably and form a tumor. The pancreas is a small, fish-shaped organ about six inches long that sits between the stomach and the spine.[1][3] It performs two essential jobs: creating enzymes that help break down food, and producing hormones like insulin that control blood sugar levels.[7]

Most pancreatic adenocarcinomas begin in the cells that line the small tubes inside the pancreas called ducts. These ducts carry digestive juices containing enzymes into the main pancreatic duct.[5] The disease can develop anywhere in the pancreas, though it most commonly appears in the head, which is the widest part of the organ.[5] The middle section is called the body, and the narrowest end is known as the tail.[3]

One of the most troubling aspects of this disease is that it typically does not cause noticeable symptoms in its early stages. Many people only begin to experience signs when the cancer has already grown large enough to affect nearby organs or has spread to other parts of the body.[1][2] This delayed detection makes pancreatic adenocarcinoma particularly difficult to treat and contributes to its reputation as one of the most challenging cancers to manage.

How Common Is This Disease

Pancreatic cancer is the second most common gastrointestinal cancer in the United States. Each year, approximately 53,000 to 67,000 people receive a diagnosis of pancreatic cancer in this country.[2][12] While pancreatic cancer represents only about 3 percent of all cancers diagnosed in the United States, it has a disproportionately high death rate.[3] It stands as the fourth leading cause of cancer-related deaths in both men and women, despite being less common than cancers of the prostate, lung, or colon.[2]

The disease shows some interesting patterns across different groups of people. It is more common in African Americans compared to other racial groups, and slightly more common in men than in women.[2] Pancreatic adenocarcinoma is usually a disease of older adults, with most diagnoses occurring after age 65.[1] In fact, it rarely occurs before the age of 40, and more than half of all cases are diagnosed in people over 70 years old.[6]

The incidence of pancreatic cancer has been steadily increasing over recent decades. Current trends suggest that by 2030, pancreatic cancer may become the second leading cause of cancer death in the United States, highlighting the urgent need for better detection and treatment methods.[3] Globally, around 460,000 people are diagnosed with pancreatic cancer each year, and it causes approximately 430,000 deaths worldwide.[15]

What Causes Pancreatic Adenocarcinoma

The exact cause of pancreatic adenocarcinoma remains unclear, and researchers are still working to understand why this disease develops. What scientists do know is that the cancer begins when small changes occur in the DNA (the genetic material inside cells) of pancreatic cells. These changes cause the cells to grow and divide in an uncontrolled way, eventually forming clusters called tumors.[1] If left untreated, these abnormal cells can spread beyond the pancreas to other parts of the body through a process called metastasis.[6]

While we cannot point to a single cause, experts have identified several factors that increase the likelihood of developing this disease. These are called risk factors, and understanding them can help people make informed choices about their health.

⚠️ Important
Having one or more risk factors does not guarantee that someone will develop pancreatic cancer. Many people with risk factors never develop the disease, while some people without any known risk factors do. Risk factors simply indicate an increased possibility compared to the general population.

Risk Factors for Pancreatic Adenocarcinoma

Cigarette smoking stands out as one of the strongest risk factors for pancreatic adenocarcinoma. Smoking is likely associated with as many as one in four pancreatic tumors, making it a significant contributor to the disease.[2] The harmful chemicals in tobacco smoke damage cells throughout the body, including those in the pancreas, increasing the chance that these cells will develop cancer. This applies not only to cigarettes but also to cigars and other forms of tobacco use.[3]

Diabetes mellitus, particularly type 2 diabetes (a condition where the body cannot properly use or produce insulin), plays a complex role in pancreatic cancer development. People with type 2 diabetes often experience years or decades of insulin resistance (when cells don’t respond well to insulin), which leads to higher than normal levels of insulin in the blood. Insulin has properties that can encourage cell growth, which may help explain why diabetes is connected to various types of cancer, including pancreatic adenocarcinoma.[2] Interestingly, new-onset diabetes can sometimes be an early sign of pancreatic cancer itself.[3][7]

Carrying extra body weight, especially obesity, increases the risk of developing pancreatic cancer. Where the extra weight is located on the body also matters, with abdominal fat appearing particularly concerning.[3] A sedentary lifestyle and poor dietary habits compound these risks. Research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer more than any single factor alone.[1]

Chronic pancreatitis (long-term inflammation of the pancreas) is another risk factor. This ongoing inflammation can damage the pancreas over time and create an environment where cancer is more likely to develop.[2][7] Heavy alcohol use contributes to pancreatitis and is therefore indirectly linked to pancreatic cancer risk.[2]

Family history plays a role as well. People who have close relatives with pancreatic cancer face a higher risk of developing the disease themselves.[7][12] Certain inherited genetic conditions also increase risk, including hereditary nonpolyposis colon cancer (also called Lynch syndrome), hereditary breast and ovarian cancer syndrome (often involving mutations in the BRCA1 or BRCA2 genes), and several other rare genetic syndromes.[1][7][12]

When multiple risk factors are present together, their effects can combine and multiply, creating an even greater risk than would be expected from adding them up individually.[2] This synergistic effect underscores the importance of addressing modifiable risk factors like smoking and maintaining a healthy weight.

Signs and Symptoms

Unfortunately, early-stage pancreatic adenocarcinoma rarely causes symptoms that would alert someone to its presence. This silent nature in the beginning stages is one reason why the disease often goes undetected until it has progressed.[1][2] Symptoms typically only become noticeable once the tumor has grown large enough to press on nearby organs or block important structures in the digestive system.

When symptoms do appear, they can be vague and easily mistaken for other, less serious conditions like indigestion or a stomach ulcer. Some people develop vague symptoms up to one year before receiving a diagnosis.[3] Many patients report that their first noticeable symptoms were pain in the back or stomach area. This pain can come and go initially but may worsen after eating meals or when lying down.[3]

Jaundice (yellowing of the skin and the whites of the eyes) is a common and distinctive symptom. This occurs when the tumor blocks the bile duct, preventing bile from flowing normally from the liver to the intestine. Along with the yellow appearance of skin, jaundice often causes dark-colored urine and light-colored or pale stools.[3][7] The backup of bile can also lead to intense itching of the skin, which can be quite uncomfortable.[3]

Pain is another frequent complaint. Patients may experience discomfort in the upper or middle part of the abdomen, which sometimes radiates to the middle of the back. This pain results from the tumor pressing on nerves or other structures near the pancreas.[3][7]

Digestive problems often accompany pancreatic adenocarcinoma. These can include nausea, vomiting, gas, and bloating. Many patients feel full quickly when eating or experience a general lack of appetite, which contributes to another common symptom: unexplained weight loss.[3][7] Even when people try to maintain their normal diet, they may lose weight because the tumor interferes with digestion and the body’s ability to absorb nutrients.

Extreme tiredness or fatigue is common and can result from the cancer itself, poor nutrition, or the body’s response to the disease.[3] Some patients also develop blood clots or notice the sudden onset of diabetes without other obvious causes, which should prompt further investigation.[3][7]

Prevention and Risk Reduction

While pancreatic adenocarcinoma cannot be completely prevented, there are steps people can take to reduce their risk. The most impactful change someone can make is to stop smoking or never start. Given that smoking contributes to roughly 25 percent of pancreatic cancers, quitting tobacco use significantly lowers risk and brings numerous other health benefits as well.[2]

Maintaining a healthy body weight through a balanced diet and regular physical activity is another important preventive measure. This approach not only reduces cancer risk but also helps prevent or manage diabetes, which itself is a risk factor for pancreatic cancer. A diet rich in fruits, vegetables, whole grains, and lean proteins supports overall health, while limiting red meat, processed foods, and sugary items may offer protective benefits.[7]

Limiting alcohol consumption is advisable, as heavy drinking can lead to chronic pancreatitis, which increases cancer risk. Managing chronic health conditions like diabetes and pancreatitis with the help of healthcare providers is also important for reducing long-term risk.[2]

For people with a family history of pancreatic cancer or known genetic mutations that increase risk, regular consultations with healthcare providers are essential. In some cases, doctors may recommend genetic counseling and testing to better understand inherited risk. Individuals with certain genetic syndromes may benefit from specialized screening programs, though routine screening for the general population is not currently recommended due to the rarity of the disease and limitations of available screening methods.[2][7]

How the Disease Affects the Body

Understanding how pancreatic adenocarcinoma changes normal body functions helps explain many of the symptoms patients experience. The disease disrupts the pancreas’s normal activities in producing digestive enzymes and hormones. When tumors block the pancreatic duct or invade the pancreatic tissue itself, the organ cannot release enough enzymes into the small intestine to properly break down food, especially fats.[2] This leads to poor digestion and absorption of nutrients, contributing to weight loss and nutritional deficiencies.

The pancreas also produces insulin and other hormones that regulate blood sugar. When cancer damages these hormone-producing cells, it can lead to diabetes or worsen existing diabetes. This explains why some patients first discover they have pancreatic cancer after developing sudden, unexplained diabetes.[7]

As tumors grow, they can press on or invade nearby structures. The pancreas sits close to major blood vessels, the stomach, the small intestine, and the bile duct. When a tumor grows into the bile duct, which carries bile from the liver and gallbladder to the intestine, bile cannot flow normally. This backup causes jaundice and affects the body’s ability to digest fats and absorb certain vitamins.[3]

Tumors can also wrap around or grow into blood vessels, including the portal vein and superior mesenteric vein, which carry blood from the intestines to the liver. In some cases, even major arteries like the superior mesenteric artery or celiac artery can be affected. When blood vessels are compromised, it complicates treatment options and can affect blood flow to vital organs.[14]

Cancer cells from pancreatic adenocarcinoma can break away from the primary tumor and travel through the bloodstream or lymphatic system to other parts of the body. Common sites where pancreatic cancer spreads include the liver, lungs, and the membrane lining the abdominal cavity (peritoneum). Approximately 80 percent of patients have cancer that has spread to lymph nodes or distant organs by the time they receive a diagnosis.[2]

The disease also triggers systemic changes throughout the body. Many pancreatic cancers release compounds into the bloodstream that break down muscle and fat tissue, a condition called cachexia. This process causes progressive weakness and weight loss even when patients try to eat well and maintain their nutrition. The body’s inflammatory response to cancer contributes to fatigue, loss of appetite, and overall decline in wellbeing.[19]

Ongoing Clinical Trials on Adenocarcinoma pancreas

  • A Study of Olaparib Maintenance Treatment for Patients with Metastatic Pancreatic Cancer That Responded to First-Line Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • A study testing ASP3082 in patients with advanced or spreading non-small cell lung cancer and pancreatic ductal adenocarcinoma

    Recruiting

    2 1 1 1
    France
  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

    Recruiting

    2 1 1 1
    Belgium France Italy Spain
  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Germany
  • Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy

    Recruiting

    2 1 1
    Investigated diseases:
    France
  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Poland Spain
  • Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

    Recruiting

    2 1 1
    Spain
  • A Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Belgium Italy The Netherlands Poland Spain

References

https://www.mayoclinic.org/diseases-conditions/pancreatic-cancer/symptoms-causes/syc-20355421

https://pmc.ncbi.nlm.nih.gov/articles/PMC6140147/

https://my.clevelandclinic.org/health/diseases/15806-pancreatic-cancer

https://pancan.org/facing-pancreatic-cancer/about-pancreatic-cancer/types-of-pancreatic-cancer/

https://www.pancreaticcancer.org.uk/information/just-diagnosed-with-pancreatic-cancer/pancreatic-ductal-adenocarcinoma-and-other-exocrine-tumours/

https://en.wikipedia.org/wiki/Pancreatic_cancer

https://www.cancer.gov/types/pancreatic/patient/pancreatic-treatment-pdq

https://www.mayoclinic.org/diseases-conditions/pancreatic-cancer/diagnosis-treatment/drc-20355427

https://pmc.ncbi.nlm.nih.gov/articles/PMC6763942/

https://www.cancer.org/cancer/types/pancreatic-cancer/treating.html

https://www.mdanderson.org/cancer-types/pancreatic-cancer/pancreatic-cancer-treatment.html

https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq

https://my.clevelandclinic.org/health/diseases/15806-pancreatic-cancer

https://emedicine.medscape.com/article/280605-treatment

https://www.cancerresearch.org/immunotherapy-by-cancer-type/pancreatic-cancer

https://pancan.org/news/diagnosis-finding-new-normal/

https://columbiasurgery.org/pancreas/coping

https://www.trovanow.com/tips-for-pancreatic-cancer-patients-to-stay-healthy-and-active/

https://pathology.jhu.edu/pancreas/quality-life

https://cancerblog.mayoclinic.org/2022/11/15/people-with-pancreatic-cancer-are-living-longer-thanks-to-improved-approaches/

https://www.projectpurple.org/what-to-do-next-when-youve-been-diagnosed-with-pancreatic-cancer/

FAQ

Why is pancreatic adenocarcinoma so hard to detect early?

Pancreatic adenocarcinoma rarely causes symptoms in its early stages because the pancreas is located deep in the body behind other organs. Early-stage tumors don’t show up well on standard imaging tests, and the vague symptoms that eventually develop—like back pain or digestive issues—are easily mistaken for more common, less serious conditions. By the time distinctive symptoms like jaundice appear, the cancer has often already grown significantly or spread.

What does the survival rate mean for individual patients?

The overall one-year and five-year survival rates for pancreatic cancer are 24 percent and 6 percent respectively. However, these are population-wide statistics and don’t predict what will happen for any individual person. Survival depends on many factors including the stage at diagnosis, the specific characteristics of the tumor, the patient’s overall health, and how well the cancer responds to treatment. Some patients live much longer than average, especially when the cancer is caught early and can be completely removed by surgery.

Can pancreatic adenocarcinoma be inherited?

While most pancreatic cancers are not directly inherited, about 10 percent or fewer are linked to genetic factors. Certain hereditary conditions significantly increase risk, including Lynch syndrome, hereditary breast and ovarian cancer syndrome (with BRCA gene mutations), and several other rare genetic syndromes. Having a family history of pancreatic cancer, even without an identified genetic mutation, also increases risk. People with these risk factors should discuss genetic counseling and testing with their healthcare providers.

How is pancreatic adenocarcinoma different from other pancreatic cancers?

Pancreatic adenocarcinoma accounts for 90 to 95 percent of all pancreatic cancers and develops in the cells lining the ducts that produce digestive enzymes. The remaining 5 to 10 percent are neuroendocrine tumors (also called islet cell tumors), which develop in hormone-producing cells. Neuroendocrine tumors generally grow more slowly and have a better prognosis than adenocarcinoma. The two types require different treatment approaches.

Does having diabetes mean I will get pancreatic cancer?

No. While diabetes is associated with increased risk of pancreatic cancer, most people with diabetes never develop this disease. Type 2 diabetes involves years of elevated insulin levels, and insulin’s growth-promoting properties may contribute to cancer development in some cases. Interestingly, pancreatic cancer can also cause diabetes by damaging the insulin-producing cells. New-onset diabetes in older adults, especially with other symptoms, should prompt evaluation to rule out pancreatic cancer.

🎯 Key takeaways

  • Pancreatic adenocarcinoma makes up 90 to 95 percent of all pancreatic cancers and starts in the cells lining the ducts that produce digestive enzymes.
  • About 53,000 to 67,000 Americans are diagnosed with pancreatic cancer each year, with most cases occurring in people over 65 years old.
  • Cigarette smoking is linked to approximately 25 percent of pancreatic tumors, making it the strongest modifiable risk factor for this disease.
  • The disease rarely causes early symptoms, and approximately 80 percent of patients have cancer that has already spread by the time of diagnosis.
  • Common symptoms include jaundice, abdominal or back pain, unexplained weight loss, digestive problems, and new-onset diabetes.
  • The combination of smoking, diabetes, and poor diet increases pancreatic cancer risk more than any single factor alone.
  • Family history and certain genetic mutations (like BRCA1, BRCA2, and Lynch syndrome) significantly increase the risk of developing pancreatic adenocarcinoma.
  • Maintaining a healthy weight, not smoking, limiting alcohol, and eating a balanced diet can help reduce the risk of developing this disease.